title: A closed system for the clinical banking of umbilical cord blood.
abstract: Umbilical cord blood (UCB) is a source of hematopoietic progenitor cells and is used as an alternative to the bone marrow or peripheral blood for treatment of several onco-hematological diseases. Because of the limited number of CD34+ hematopoietic stem cells present in UCB units and of the elevated costs of cryopreservation, it is of paramount importance to select the UCB units that are clinically useful before storage and optimize banking efficiency by designing reliable procedures to process and freeze the selected units. Among the different parameters characterizing UCB, nucleated cell (NC) and CD34+ cell content provides useful criteria to select UCB units since clinical data documented that the infused cell load (both NC and CD34+ cells) plays an important role in the successful outcome of transplants. By evaluating volume, CD34+ cell content, NC total amount, and NC density of 117 UCB units, we found a significant association between CD34+ cell content and NC density and total amount, indicating these parameters as useful to decide UCB clinical utility. Furthermore, we set up a fast procedure to process UCB units for storage. A system for NC separation and volume reduction of UCB samples in a dedicated, germ-free, closed circuit was developed, where plasma and red blood cells (RBC) depletion was obtained by sedimentation in the presence of a 3.5% Polygeline solution. By this separation system, both RBC depletion and high NC and CD34+ cell recoveries were achieved in 60 min, and the yield was comparable to the one obtained by other separation methods. Since Polygeline has been clinically used as a plasma expander and no toxic effects on patients were reported, the protocol can be applied in the large-scale banking of UCB.
authors.affiliation: Consorzio Fenice, University of Udine, Italy.
authors.forename: V
authors.initials: V
authors.lastname: Adami
authors.forename: W
authors.initials: W
authors.lastname: Malangone
authors.forename: E
authors.initials: E
authors.lastname: Falasca
authors.forename: L
authors.initials: L
authors.lastname: Marini
authors.forename: A
authors.initials: A
authors.lastname: Risso
authors.forename: S
authors.initials: S
authors.lastname: Crini
authors.forename: E
authors.initials: E
authors.lastname: Toniutti
authors.forename: E
authors.initials: E
authors.lastname: Passoni Ferraro
authors.forename: G
authors.initials: G
authors.lastname: Del Frate
authors.forename: M
authors.initials: M
authors.lastname: Pittino
authors.forename: F
authors.initials: F
authors.lastname: Biffoni
authors.forename: C
authors.initials: C
authors.lastname: Rinaldi
authors.forename: A
authors.initials: A
authors.lastname: Degrassi
mesh_terms: D018952:Antigens, CD34 / Q000032:analysis; D001771:Blood Banks; D001793:Blood Preservation; D002469:Cell Separation; D002478:Cells, Cultured; D003114:Colony-Forming Units Assay; D015925:Cryopreservation; D005312:Fetal Blood / Q000166:cytology*; D005434:Flow Cytometry; D006412:Hematopoietic Stem Cells / Q000166:cytology; D006801:Humans; D007958:Leukocyte Count; D011097:Polygeline / Q000737:chemistry; D013048:Specimen Handling
chemical_list: D018952:Antigens, CD34; D011097:Polygeline